Cardiac Biomarkers Market By Type (Troponin, Creatine kinase - MB (CK-MB), Natriuretic peptides - B-type Natriuretic Peptide (BNP) & N-terminal pro b-type Natriuretic peptide (NT-proBNP), Myoglobin, Ischemia Modified Albumin (IMA), Heart-type Fatty Acid Binding Protein (H-FABP), LDH isoenzymes), By Application (Acute Coronary Syndrome, Myocardial infarction, Congestive heart failure, Cardiomyopathy, Ischemia, Myocarditis, Atrial fibrillation), By End Use, By Region And Segment Forecasts To 2024Report

Cardiac Biomarkers Market By Type (Troponin, Creatine kinase - MB (CK-MB), Natriuretic peptides - B-type Natriuretic Peptide (BNP) & N-terminal pro b-type Natriuretic peptide (NT-proBNP), Myoglobin, Ischemia Modified Albumin (IMA), Heart-type Fatty Acid Binding Protein (H-FABP), LDH isoenzymes), By Application (Acute Coronary Syndrome, Myocardial infarction, Congestive heart failure, Cardiomyopathy, Ischemia, Myocarditis, Atrial fibrillation), By End Use, By Region And Segment Forecasts To 2024

  • Published Date: Sep, 2016
  • Base Year for Estimate: 2015
  • Report ID: GVR-1-68038-083-5
  • Format: Electronic (PDF)
  • Historical Data: 2013-2015
  • Number of Pages: 91

Table of Content

Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Market Snapshot
Chapter 4. Market Variables, Trends & Scope
                    4.1. Market segmentation & scope
                    4.2. Cardiac biomarkers: Market dynamics
                         4.2.1. Market driver analysis
                         4.2.2. Market restraint analysis
                    4.3. Penetration & growth prospect mapping
                    4.4. Cardiac Biomarkers - SWOT Analysis, By Factor (political & legal, economic and technological)
                    4.5. Industry Analysis - Porter’s
                    4.6. Cardiac Biomarkers Market: Company Market Share Analysis, 2015
Chapter 5. Market Categorization 1: Cardiac Biomarkers Type Estimates & Trend Analysis
                    5.1. Cardiac Biomarkers Market: Type Movement Analysis
                    5.2. Troponin
                         5.2.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
                    5.3. CK-MB
                         5.3.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
                    5.4. Natriuretic Peptides (BNP and NT-proBNP)
                         5.4.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
                    5.5. Myoglobin
                         5.5.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
                    5.6. Others
                         5.6.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
Chapter 6. Market Categorization 2: Cardiac Biomarkers Application Estimates & Trend Analysis
                    6.1. Cardiac Biomarkers Market: Application Movement Analysis
                    6.2. Acute Myocardial Infarction (AMI)
                         6.2.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
                    6.3. Congestive Heart Failure (CHF)
                         6.3.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
                    6.4. Acute Coronary Syndrome (ACS)
                         6.4.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
                    6.5. Others
                         6.5.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
Chapter 7. Market Categorization 3: Cardiac Biomarkers End-use Estimates & Trend Analysis
                    7.1. Cardiac Biomarkers Market: End-use Movement Analysis
                    7.2. Laboratory Testing
                         7.2.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
                    7.3. Point of Care Testing
                         7.3.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
Chapter 8. Cardiac biomarkers: Regional Estimates & Trend Analysis, by Type, Application, & End-use
                    8.1. Cardiac biomarkers Market Share (%) Analysis, by Region, 2016 & 2024
                    8.2. North America
                         8.2.1. The U.S.
                               8.2.1.1. U.S. Cardiac biomarkers market, by type, 2013 - 2024 (USD Million)
                               8.2.1.2. U.S. Cardiac biomarkers market, by application, 2013 - 2024 (USD Million)
                               8.2.1.3. U.S. Cardiac biomarkers market, by end-use, 2013 - 2024 (USD Million)
                         8.2.2. Canada
                               8.2.2.1. Canada Cardiac biomarkers market, by type, 2013 - 2024 (USD Million)
                               8.2.2.2. Canada Cardiac biomarkers market, by application, 2013 - 2024 (USD Million)
                               8.2.2.3. Canada Cardiac biomarkers market, by end-use, 2013 - 2024 (USD Million)
                    8.3. Europe
                         8.3.1. Germany
                               8.3.1.1. Germany Cardiac biomarkers market, by type, 2013 - 2024 (USD Million)
                               8.3.1.2. Germany Cardiac biomarkers market, by application, 2013 - 2024 (USD Million)
                               8.3.1.3. Germany Cardiac biomarkers market, by end-use, 2013 - 2024 (USD Million)
                         8.3.2. UK
                               8.3.2.1. UK Cardiac biomarkers market, by type, 2013 - 2024 (USD Million)
                               8.3.2.2. UK Cardiac biomarkers market, by application, 2013 - 2024 (USD Million)
                               8.3.2.3. UK Cardiac biomarkers market, by end-use, 2013 - 2024 (USD Million)
                    8.4. Asia Pacific
                         8.4.1. China
                               8.4.1.1. China Cardiac biomarkers market, by type, 2013 - 2024 (USD Million)
                               8.4.1.2. China Cardiac biomarkers market, by application, 2013 - 2024 (USD Million)
                               8.4.1.3. China Cardiac biomarkers market, by end-use, 2013 - 2024 (USD Million)
                         8.4.2. India
                               8.4.2.1. India Cardiac biomarkers market, by type, 2013 - 2024 (USD Million)
                               8.4.2.2. India Cardiac biomarkers market, by application, 2013 - 2024 (USD Million)
                               8.4.2.3. India Cardiac biomarkers market, by end-use, 2013 - 2024 (USD Million)
                    8.5. Latin America
                         8.5.1. Brazil
                               8.5.1.1. Brazil cardiac biomarkers market, by type, 2013 - 2024 (USD Million)
                               8.5.1.2. Brazil cardiac biomarkers market, by application, 2013 - 2024 (USD Million)
                               8.5.1.3. Brazil cardiac biomarkers market, by end-use, 2013 - 2024 (USD Million)
                         8.5.2. Mexico
                               8.5.2.1. Mexico cardiac biomarkers market, by type, 2013 - 2024 (USD Million)
                               8.5.2.2. Mexico cardiac biomarkers market, by application, 2013 - 2024 (USD Million)
                               8.5.2.3. Mexico cardiac biomarkers market, by end-use, 2013 - 2024 (USD Million)
                    8.6. Middle East Africa
                         8.6.1. South Africa
                               8.6.1.1. South Africa cardiac biomarkers market, by type, 2013 - 2024 (USD Million)
                               8.6.1.2. South Africa cardiac biomarkers market, by application, 2013 - 2024 (USD Million)
                               8.6.1.3. South Africa cardiac biomarkers market, by end-use, 2013 - 2024 (USD Million)
                         8.6.2. Middle East
                               8.6.2.1. Middle East cardiac biomarkers market, by type, 2013 - 2024 (USD Million)
                               8.6.2.2. Middle East cardiac biomarkers market, by application, 2013 - 2024 (USD Million)
                               8.6.2.3. Middle East cardiac biomarkers market, by end-use, 2013 - 2024 (USD Million)
Chapter 9. Competitive Landscape
                    9.1. Company Profiles
                         9.1.1. Abbott Laboratories
                               9.1.1.1. Company Overview
                               9.1.1.2. Financial Performance
                               9.1.1.3. Product Benchmarking
                               9.1.1.4. Strategic Initiatives
                         9.1.2. Alere, Inc.
                               9.1.2.1. Company Overview
                               9.1.2.2. Financial Performance
                               9.1.2.3. Product Benchmarking
                               9.1.2.4. Strategic Initiatives
                         9.1.3. Siemens Healthcare GmbH
                               9.1.3.1. Company Overview
                               9.1.3.2. Financial Performance
                               9.1.3.3. Product Benchmarking
                               9.1.3.4. Strategic Initiatives
                         9.1.4. Roche Diagnostics Corporation
                               9.1.4.1. Company Overview
                               9.1.4.2. Financial Performance
                               9.1.4.3. Product Benchmarking
                               9.1.4.4. Strategic Initiatives
                         9.1.5. Beckman Coulter, Inc.
                               9.1.5.1. Company Overview
                               9.1.5.2. Financial Performance
                               9.1.5.3. Product Benchmarking
                               9.1.5.4. Strategic Initiatives
                         9.1.6. Becton, Dickinson &Co.
                               9.1.6.1. Company Overview
                               9.1.6.2. Financial Performance
                               9.1.6.3. Product Benchmarking
                               9.1.6.4. Strategic Initiatives
                         9.1.7. Thermo Fisher Scientific, Inc.
                               9.1.7.1. Company Overview
                               9.1.7.2. Financial Performance
                               9.1.7.3. Product Benchmarking
                               9.1.7.4. Strategic Initiatives
                         9.1.8. bioMérieux SA
                               9.1.8.1. Company Overview
                               9.1.8.2. Financial Performance
                               9.1.8.3. Product Benchmarking
                               9.1.8.4. Strategic Initiatives
                         9.1.9. Bio-Rad Laboratories, Inc.
                               9.1.9.1. Company Overview
                               9.1.9.2. Financial Performance
                               9.1.9.3. Product Benchmarking
                               9.1.9.4. Strategic Initiatives
                         9.1.10. BG Medicines
                               9.1.10.1. Company Overview
                               9.1.10.2. Financial Performance
                               9.1.10.3. Product Benchmarking
                               9.1.10.4. Strategic Initiatives


List of Tables

1. Cardiac biomarkers market - Industry Snapshot & Key Buying Criteria, 2013 - 2024
2. Cardiac biomarkers market revenue, by type, 2013 - 2024 (USD Million)
3. Cardiac biomarkers market revenue, by application, 2013 - 2024 (USD Million)
4. Cardiac biomarkers market revenue, by end-use, 2013 - 2024 (USD Million)
5. Cardiac biomarkers market, by region, 2013 - 2024 (USD Million)
6. Cardiac biomarkers- Key Market Driver Analysis
7. Cardiac biomarkers- Key Market Restraint Analysis
8. North America cardiac biomarkers market revenue, by type, 2013 - 2024 (USD Million)
9. North America cardiac biomarkers market revenue, by application type, 2013 - 2024 (USD Million)
10. North America cardiac biomarkers market revenue, by end-use, 2013 - 2024 (USD Million)
11. U.S. cardiac biomarkers market revenue, by type, 2013 - 2024 (USD Million)
12. U.S. cardiac biomarkers market revenue, by application, 2013 - 2024 (USD Million)
13. U.S. cardiac biomarkers market revenue, by end-use, 2013 - 2024 (USD Million)
14. Canada cardiac biomarkers market revenue, by type, 2013 - 2024 (USD Million)
15. Canada cardiac biomarkers market revenue, by application, 2013 - 2024 (USD Million)
16. Canada cardiac biomarkers market revenue, by end-use, 2013 - 2024 (USD Million)
17. Europe cardiac biomarkers market revenue, by type, 2013 - 2024 (USD Million)
18. Europe cardiac biomarkers market revenue, by application, 2013 - 2024 (USD Million)
19. Europe cardiac biomarkers market revenue, by end-use, 2013 - 2024 (USD Million)
20. Germany cardiac biomarkers market revenue, by type, 2013 - 2024 (USD Million)
21. Germany cardiac biomarkers market revenue, by application, 2013 - 2024 (USD Million)
22. Germany cardiac biomarkers market revenue, by end-use, 2013 - 2024 (USD Million)
23. UK cardiac biomarkers market revenue, by type, 2013 - 2024 (USD Million)
24. UK cardiac biomarkers market revenue, by application, 2013 - 2024 (USD Million)
25. UK cardiac biomarkers market revenue, by end-use, 2013 - 2024 (USD Million)
26. Asia Pacific cardiac biomarkers market revenue, by type, 2013 - 2024 (USD Million)
27. Asia Pacific cardiac biomarkers market revenue, by application, 2013 - 2024 (USD Million)
28. Asia Pacific cardiac biomarkers market revenue, by end-use, 2013 - 2024 (USD Million)
29. China cardiac biomarkers market revenue, by type, 2013 - 2024 (USD Million)
30. China cardiac biomarkers market revenue, by application, 2013 - 2024 (USD Million)
31. China cardiac biomarkers market revenue, by end-use, 2013 - 2024 (USD Million)
32. India cardiac biomarkers market revenue, by type, 2013 - 2024 (USD Million)
33. India cardiac biomarkers market revenue, by application, 2013 - 2024 (USD Million)
34. India cardiac biomarkers market revenue, by end-use, 2013 - 2024 (USD Million)
35. Brazil cardiac biomarkers market revenue, by type, 2013 - 2024 (USD Million)
36. Brazil cardiac biomarkers market revenue, by application, 2013 - 2024 (USD Million)
37. Brazil cardiac biomarkers market revenue, by end-use, 2013 - 2024 (USD Million)
38. Mexico cardiac biomarkers market revenue, by type, 2013 - 2024 (USD Million)
39. Mexico cardiac biomarkers market revenue, by application, 2013 - 2024 (USD Million)
40. Mexico cardiac biomarkers market revenue, by end-use, 2013 - 2024 (USD Million)
41. MEA cardiac biomarkers market revenue, by type, 2013 - 2024 (USD Million)
42. MEA cardiac biomarkers market revenue, by application, 2013 - 2024 (USD Million)
43. MEA cardiac biomarkers market revenue, by end-use, 2013 - 2024 (USD Million)
44. South Africa cardiac biomarkers market revenue, by type, 2013 - 2024 (USD Million)
45. South Africa cardiac biomarkers market revenue, by application, 2013 - 2024 (USD Million)
46. South Africa cardiac biomarkers market revenue, by end-use, 2013 - 2024 (USD Million)
47. Middle East cardiac biomarkers market revenue, by type, 2013 - 2024 (USD Million)
48. Middle East cardiac biomarkers market revenue, by application, 2013 - 2024 (USD Million)
49. Middle East cardiac biomarkers market revenue, by end-use, 2013 - 2024 (USD Million)


List of Figures

1. Market research process
2. Information procurement
3. Primary research pattern
4. Market research approaches
5. QFD modeling for market share assessment
6. Market summary
7. Market trends & outlook
8. Cardiac biomarkers: Market segmentation& scope
9. Cardiac biomarkers market driver relevance analysis (Current & future impact)
10. SWOT Analysis, By Factor (political & legal, economic and technological)
11. Cardiac biomarkers market: Porter’s Five Forces Analysis
12. Cardiac biomarkers market: Company Market Share Analysis, 2015
13. Key opportunities prioritized
14. cardiac biomarkers market key takeaways
15. cardiac biomarkers market type outlook: Key takeaways
16. Troponin cardiac biomarkers market, 2013 - 2024 (USD Million)
17. CK-MB cardiac biomarkers market, 2013 - 2024 (USD Million)
18. BNP and NT-proBNP cardiac biomarkers market, 2013 - 2024 (USD Million)
19. Myoglobin cardiac biomarkers market, 2013 - 2024 (USD Million)
20. Others cardiac biomarkers market, 2013 - 2024 (USD Million)
21. Cardiac biomarkers market application outlook: Key takeaways
22. Acute Coronary Syndrome cardiac biomarkers market, 2013 - 2024 (USD Million)
23. Myocardial infarction cardiac biomarkers market, 2013 - 2024 (USD Million)
24. Congestive heart failure cardiac biomarkers market, 2013 - 2024 (USD Million)
25. Others cardiac biomarkers market, 2013 - 2024 (USD Million)
26. Cardiac biomarkers market end-user outlook: Key takeaways
27. Laboratory Testing cardiac biomarkers market, 2013 - 2024 (USD Million)
28. Point of Care Testing cardiac biomarkers market, 2013 - 2024 (USD Million)
29. Regional market place: Key takeaways
30. Regional outlook, 2016 & 2024

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.